Retinitis pigmentosa (RP) is a hereditary and blinding retinal disease1. The incidence of RP is between 1/3500 and 1/5000, affecting the visual function of about 2.5 million people in the world. It is one of the most well-known diseases leading to visual impairment in human beings, imposing a significant burden on the whole society2. The disease is characterized by the gradual loss of retinal pigment epithelial cell function and the progressive apoptosis of photoreceptors. In the early stage, patients experience night blindness, which manifests as peripheral visual field defects and eventually leads to the loss of central vision3. Therefore, inhibition of retinal photoreceptor apoptosis is the pointcut for the prevention and treatment of RP.
Retinal cell apoptosis is a common feature of human RP and model animals4. Intraperitoneal injection of 60 mg/kg N-Methyl-N-Nitrosourea (MNU) in rats for 7 days can induce apoptosis and loss of retinal photoreceptor cells, and it is a commonly used animal model of RP5,6. Analyzing the changes in pathological structure, specific cell apoptosis, and apoptosis-related protein expression of retinal tissue in model animals can provide effective experimental data and theoretical support in studying the pathogenesis of human RP and screening drugs7,8. Therefore, the quality of retinal specimens determines the reliability of experimental data. However, due to the particularity of ocular tissue, there are very few reports on how to get the rat retina9.
This paper provides a simple, fast, standardized, and operable procedure for retinal sampling in rats to overcome the above shortcomings. Hematoxylin-eosin staining (HE), terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate-digoxigenin nick-end labeling (TUNEL) staining, and Western blot are used to analyze the pathological changes in retinal tissue damage and apoptosis in the rats. All the methods are derived from our research group's experience with the specific operational processes.